DURRANT, Linda Gillian,BRENTVILLE, Victoria Anne,METHERINGHAM, Rachel Louise
申请号：
HK18107761
公开号：
HK1248253A1
申请日:
2018.06.14
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
The present invention relates to modified citrullinated enolase peptides that can be used as targets for cancer immunotherapy. These peptides can be used as vaccines or as targets for monoclonal antibody (mAb) therapy. Such vaccines or mAbs may be used in the treatment of cancer.
